---
title: "Evotec CFO Paul Hitchin Resigns; Names Claire Hinshelwood Replacement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283944181.md"
description: "Evotec SE announced the resignation of CFO Paul Hitchin, effective April 30, due to personal reasons. Claire Hinshelwood will take over as CFO starting May 1. Hinshelwood brings over 30 years of financial leadership experience, previously serving as CFO at BMI Group. Following the announcement, Evotec's shares rose 1.55% to $3.28 after hours."
datetime: "2026-04-24T06:24:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283944181.md)
  - [en](https://longbridge.com/en/news/283944181.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283944181.md)
---

# Evotec CFO Paul Hitchin Resigns; Names Claire Hinshelwood Replacement

Add  as your preferred news source on Google

 Add Now

Evotec SE (EVO,EVTG.DE,EVTCY.PK), a life science company, announced Friday that its CFO Paul Hitchin will leave the company on April 30, "citing personal reasons unrelated to Evotec."

Claire Hinshelwood has been named the new financial chief effective May 1, the company said in a statement.

Hinshelwood has over 30 years of financial leadership experience and was most recently served at BMI Group as CFO.

On the Nasdaq, shares of Evotec were gaining 1.55 percent after hours at $3.28 after closing Thursday's regular trading at $3.23.

For comments and feedback contact: editorial@rttnews.com

Business News

### Related Stocks

- [EVO.US](https://longbridge.com/en/quote/EVO.US.md)
- [EVT.DE](https://longbridge.com/en/quote/EVT.DE.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [Liminatus Pharma Announces Proposed Merger with InnocsAI to Expand Oncology Cell Therapy Pipeline | LIMN Stock News](https://longbridge.com/en/news/287218720.md)
- [Korro Bio To Advance KRRO-111 As Potential Treatment For AATD](https://longbridge.com/en/news/287089978.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts | ONC Stock News](https://longbridge.com/en/news/287198763.md)